Tubulin-binding agents down-regulate matrix metalloproteinase-2 and -9 in human hormone-refractory prostate cancer cells – A critical role of Cdk1 in mitotic entry
- 1 March 2015
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 94 (1) , 12-21
Abstract
No abstract availableKeywords
Funding Information
- National Science Council of the Republic of China (NSC101-2923-B-002-008-MY3, NSC101-2320-B-002-018-MY3)
This publication has 34 references indexed in Scilit:
- CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signalingCytokine, 2013
- N-Terminal Truncated Intracellular Matrix Metalloproteinase-2 Induces Cardiomyocyte Hypertrophy, Inflammation and Systolic Heart FailurePLOS ONE, 2013
- Selaginella tamariscina Attenuates Metastasis via Akt Pathways in Oral Cancer CellsPLOS ONE, 2013
- The pharmacological bases of the antiangiogenic activity of paclitaxelAngiogenesis, 2013
- Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian CarcinomaPLOS ONE, 2013
- Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder CancerBMC Urology, 2012
- The Roles of Cyclin A2, B1, and B2 in Early and Late Mitotic EventsMolecular Biology of the Cell, 2010
- Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to MitosisDevelopmental Cell, 2010
- Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in MiceCancer Investigation, 2009
- Matrix metalloproteinasesEuropean Journal of Cancer, 2000